Compounding of Veterinary Drugs for Equine Practitioners
Scott D Stanley1, Krysta Moffitt1, Valerie Wiebe2
1K.L. Maddy Equine Analytical Chemistry Laboratory, School of Veterinary Medicine, University of California, Davis, 620 West Health Science Drive, Davis, CA 95616, USA.
Equine veterinarians should use compounded medications judiciously, ensuring veterinary oversight, client-patient relationships, and adherence to the Animal Medicinal Drug Use Clarification Act for safe and effective horse treatment.
Area of Science:
- Veterinary Medicine
- Pharmacology
Background:
- Compounded medications offer tailored treatments for horses but require careful consideration.
- Ensuring the safe and effective use of these medications is paramount in equine practice.
Purpose of the Study:
- To provide evidence-based recommendations for equine practitioners on the appropriate use of compounded medications.
- To outline criteria for the veterinary-driven decision-making process for compounded drug use in horses.
Main Methods:
- Recommendations are based on veterinary-driven decisions.
- Compliance with the Animal Medicinal Drug Use Clarification Act of 1994 is emphasized.
- Specific criteria for the judicious use of compounded drugs are defined.
Main Results:
- Compounded medication use must be based on a valid veterinarian-client-patient relationship.
- Use is restricted to situations where no other drug delivery method is practical.
- Application is limited to drugs with demonstrated safety, efficacy, and stability, or for conditions with quantifiable monitoring.
Conclusions:
- Adherence to these guidelines ensures responsible and ethical use of compounded medications in equine practice.
- These recommendations support evidence-based medicine and regulatory compliance for improved horse health outcomes.
More Related Videos
10:31Surgical Angiogenesis in Porcine Tibial Allotransplantation: A New Large Animal Bone Vascularized Composite Allotransplantation Model
Published on: August 13, 2017
08:40Author Spotlight: A Novel 3D-Printed Titanium Implant for Minimally Invasive Treatment of Hip Dysplasia in Young Dogs
Published on: April 19, 2024
Related Concept Videos
Pharmaceutical Equivalents
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Dosage Interval and Administration Route: Determination Methods
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
